Oncogenic transforming potential of nitroimidazole radiosensitizers

This publication has 10 references indexed in Scilit:

• Nitroimidazole bioreductive metabolism
  Biochemical Pharmacology, 1987
• Oncogenic transformation of cells in culture: Pragmatic comparisons of oncogenicity, cellular and molecular mechanisms
  International Journal of Radiation Oncology*Biology*Physics, 1986
• The differential cytotoxicity of RSU 1069: Cell survival studies indicating interaction with DNA as a possible mode of action
  British Journal of Cancer, 1986
• Induction of DNA strand breaks by RSU-1069, a nitroimidazole-aziridine radiosensitizer
  Biochemical Pharmacology, 1985
• In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers
  International Journal of Radiation Oncology*Biology*Physics, 1985
• RSU 1069, a 2-nitroimidazole containing an alkylating group: High efficiency as a radio- and chemosensitizer in vitro and in vivo
  International Journal of Radiation Oncology*Biology*Physics, 1984
• Radiation sensitization and chemopotentiation: Rsu 1069, a compound more efficient than misonidazole in vitro and in vivo
  British Journal of Cancer, 1984
• Sensitizers, protectors and oncogenic transformation in vitro
  International Journal of Radiation Oncology*Biology*Physics, 1982
• The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles
  International Journal of Radiation Oncology*Biology*Physics, 1982
• SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use
  International Journal of Radiation Oncology*Biology*Physics, 1981